Target intelligence / Profile preview

Magnesium-dependent vitamin D hydroxylases (CYP2R1/CYP27B1/CYP24A1)

Target
CYP2R1/CYP27B1/CYP24A1
Molecular classification
Enzyme, Cytochrome P450, Monooxygenase, Oxidoreductase
01

Overview

Magnesium-dependent enzymes involved in vitamin D metabolism are a group of cytochrome P450 hydroxylases, primarily CYP2R1 and CYP27B1, that facilitate the conversion of vitamin D into its active form, 1,25-dihydroxyvitamin D (Uwitonze & Razzaque, 2018, J Am Osteopath Assoc). Magnesium serves as an essential cofactor for these enzymes, meaning that vitamin D cannot be efficiently metabolized or activated in the presence of magnesium deficiency (Zittermann, 2013, BMC Med). Additionally, the vitamin D-binding protein (VDBP) requires magnesium to transport vitamin D metabolites to target tissues like the kidneys and bones (Uwitonze & Razzaque, 2018, J Am Osteopath Assoc). Clinical evidence suggests that patients with low magnesium levels may exhibit resistance to vitamin D supplementation, as the enzymes responsible for its activation remain underactive (Reddy & Sivakumar, 1974, Lancet). Consequently, maintaining adequate magnesium levels is vital for calcium homeostasis, bone mineralization, and the prevention of metabolic bone diseases (NIH, 2022). This synergistic relationship highlights the importance of magnesium status in the therapeutic management of vitamin D deficiency and related skeletal disorders.

Other names
Vitamin D 25-hydroxylase25-hydroxyvitamin D 1-alpha-hydroxylase24-hydroxylaseVitamin D metabolic enzymesMg-dependent CYP enzymes
02

Mechanism of action

Magnesium acts as a necessary cofactor for the cytochrome P450 enzymes (CYP2R1, CYP27B1, CYP24A1) that catalyze the hydroxylation of vitamin D; it is also required for the transport of vitamin D by the vitamin D-binding protein (VDBP) (Uwitonze & Razzaque, 2018, J Am Osteopath Assoc).

03

Biological functions

Vitamin D metabolismCalcium homeostasisBone mineralizationImmune response regulation
04

Disease associations

Vitamin D deficiencyHypomagnesemiaRicketsOsteomalaciaOsteoporosisSecondary hyperparathyroidism
05

Safety considerations

HypermagnesemiaDiarrheaHypercalcemiaRisk of toxicity in chronic kidney disease
06

Interacting drugs

Magnesium citrate

7 more in the full profile.

07

Biomarkers

Serum 25-hydroxyvitamin D [25(OH)D]Serum 1,25-dihydroxyvitamin D [1,25(OH)2D]Serum magnesiumParathyroid hormone (PTH)Urinary calcium

Beyond the preview

Go deeper on Magnesium-dependent vitamin D hydroxylases (CYP2R1/CYP27B1/CYP24A1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Magnesium-dependent vitamin D hydroxylases (CYP2R1/CYP27B1/CYP24A1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call